Evaluating tumor biology and oncological disease with positron-emission tomography
- 1 July 1998
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 8 (3) , 183-196
- https://doi.org/10.1016/s1053-4296(98)80044-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: Synthesis and in vitro evaluation of 9-{3-[18F] Fluoro-1-hydroxy-2-propoxymethyl guanineBioorganic & Medicinal Chemistry Letters, 1997
- MicroPET: a high resolution PET scanner for imaging small animalsIEEE Transactions on Nuclear Science, 1997
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PETNuclear Medicine and Biology, 1996
- Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomographyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Imaging, biodistribution and therapy potential of Halogenated tamoxifen analoguesLife Sciences, 1994
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977
- Design Considerations for a Positron Emission Transaxial Tomograph (PETT III)IEEE Transactions on Nuclear Science, 1976